Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Singer

Showing results (421-430 of 649) with videos related to

Pageof 65
Sort By:
NPJ Breast Cancer|April 17, 2026
Comparison of T-DXd-associated pulmonary toxicity in real-world settings and clinical trialsSimon Udovica, Rupert Bartsch, Christian F Singer, et al.
Fertility and Sterility|June 12, 2010
Gene expression signatures of breast tissue before and after cross-sex hormone therapy in female-to-male transsexualsEva-Katrin Bentz, Dietmar Pils, Martin Bilban, et al.
Cancer Medicine|March 2, 2019
Association between family history, mutation locations, and prevalence of BRCA1 or 2 mutations in ovarian cancer patientsChristian F Singer, Yen Y Tan, Daniela Muhr, et al.
Plos One|July 5, 2013
Response prediction to neoadjuvant chemotherapy: comparison between pre-therapeutic gene expression profiles and in vitro chemosensitivity assayChristian F Singer, Florian Klinglmüller, Rembert Stratmann, et al.
Clinical Genetics|June 19, 2013
Clinical implications of genetic testing for BRCA1 and BRCA2 mutations in AustriaC F Singer, D Muhr, C Rappaport, et al.
Molecular Genetics & Genomic Medicine|April 12, 2016
Effect of lifestyle and reproductive factors on the onset of breast cancer in female BRCA 1 and 2 mutation carriersViktoria Rieder, Mohamed Salama, Lena Glöckner, et al.
Journal of Biomedical Materials Research. Part A|August 10, 2007
Effects of topographical surface modifications of electron beam melted Ti-6Al-4V titanium on human fetal osteoblastsSabine Ponader, Eleftherios Vairaktaris, Peter Heinl, et al.
Breast Cancer Research and Treatment|November 4, 2010
The PI3 kinase/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cellsCaroline Brünner-Kubath, Waheed Shabbir, Victoria Saferding, et al.
Breast Cancer Research : BCR|September 26, 2013
Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancerRebecca A Dent, Geoffrey J Lindeman, Mark Clemons, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 22, 2010
Transient overexpression of alpha-Ca2+/calmodulin-dependent protein kinase II in the nucleus accumbens shell enhances behavioral responding to amphetamineJessica A Loweth, Bryan F Singer, Lorinda K Baker, et al.
Pageof 65

Showing results (421-430 of 649) with videos related to

Sort By:
Pageof 65
NPJ Breast Cancer|April 17, 2026
Comparison of T-DXd-associated pulmonary toxicity in real-world settings and clinical trialsSimon Udovica, Rupert Bartsch, Christian F Singer, et al.
Fertility and Sterility|June 12, 2010
Gene expression signatures of breast tissue before and after cross-sex hormone therapy in female-to-male transsexualsEva-Katrin Bentz, Dietmar Pils, Martin Bilban, et al.
Cancer Medicine|March 2, 2019
Association between family history, mutation locations, and prevalence of BRCA1 or 2 mutations in ovarian cancer patientsChristian F Singer, Yen Y Tan, Daniela Muhr, et al.
Plos One|July 5, 2013
Response prediction to neoadjuvant chemotherapy: comparison between pre-therapeutic gene expression profiles and in vitro chemosensitivity assayChristian F Singer, Florian Klinglmüller, Rembert Stratmann, et al.
Clinical Genetics|June 19, 2013
Clinical implications of genetic testing for BRCA1 and BRCA2 mutations in AustriaC F Singer, D Muhr, C Rappaport, et al.
Molecular Genetics & Genomic Medicine|April 12, 2016
Effect of lifestyle and reproductive factors on the onset of breast cancer in female BRCA 1 and 2 mutation carriersViktoria Rieder, Mohamed Salama, Lena Glöckner, et al.
Journal of Biomedical Materials Research. Part A|August 10, 2007
Effects of topographical surface modifications of electron beam melted Ti-6Al-4V titanium on human fetal osteoblastsSabine Ponader, Eleftherios Vairaktaris, Peter Heinl, et al.
Breast Cancer Research and Treatment|November 4, 2010
The PI3 kinase/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cellsCaroline Brünner-Kubath, Waheed Shabbir, Victoria Saferding, et al.
Breast Cancer Research : BCR|September 26, 2013
Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancerRebecca A Dent, Geoffrey J Lindeman, Mark Clemons, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 22, 2010
Transient overexpression of alpha-Ca2+/calmodulin-dependent protein kinase II in the nucleus accumbens shell enhances behavioral responding to amphetamineJessica A Loweth, Bryan F Singer, Lorinda K Baker, et al.
Pageof 65